Investing.com - Financial Markets Worldwide

VivoSim Labs Inc (VIVS)

NASDAQ
Symbol
Exchange
Currency
VIVS·NASDAQ·USD
4OR·Frankfurt·EUR
Currency in USD
1.800
-0.060(-3.23%)
Closed·
After Hours
1.850+0.050(+2.78%)
·
VIVS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VIVS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
1.7951.859
52 wk Range
1.41021.960
Key Statistics
Edit
Prev. Close
1.8
Open
1.85
Day's Range
1.795-1.859
52 wk Range
1.41-21.96
Volume
12.48K
Average Volume (3m)
64.5K
1-Year Change
-73.31%
Book Value / Share
3.67
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VIVS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 10
Quickly burning through cash
Unlock InvestingPro

VivoSim Labs Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Buy
Moving Averages
Strong Sell

VivoSim Labs Inc Company Profile

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
9
Market
United States

Compare VIVS to Peers and Sector

Metrics to compare
VIVS
Peers
Sector
Relationship
P/E Ratio
−2.4x−3.5x−0.5x
PEG Ratio
−0.030.020.00
Price/Book
0.5x2.5x2.6x
Price / LTM Sales
33.0x8.1x3.3x
Upside (Analyst Target)
-82.7%40.6%
Fair Value Upside
Unlock13.5%5.3%Unlock

Earnings

Latest Release
May 22, 2025
EPS / Forecast
4.21 / -2.28
Revenue / Forecast
51.00K / 46.00K
EPS Revisions
a
a
Unlock
Last 90 days

VIVS Income Statement

People Also Watch

Sarepta
20.30
SRPT
-0.49%
Cyngn
6.1700
CYN
-4.49%
Catalyst Pharmaceuticals
20.070
CPRX
-0.59%
Windtree Therapeutics
0.517
WINT
-3.55%
EXACT Sciences
44.99
EXAS
+0.18%

FAQ

What Stock Exchange Does VivoSim Labs Trade On?

VivoSim Labs is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for VivoSim Labs?

The stock symbol for VivoSim Labs is "VIVS."

What Is the VivoSim Labs Market Cap?

As of today, VivoSim Labs market cap is 4.68M.

What Is VivoSim Labs's Earnings Per Share (TTM)?

The VivoSim Labs EPS (TTM) is -1.11.

From a Technical Analysis Perspective, Is VIVS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has VivoSim Labs Stock Split?

VivoSim Labs has split 3 times.

How Many Employees Does VivoSim Labs Have?

VivoSim Labs has 9 employees.

What is the current trading status of VivoSim Labs (VIVS)?

As of 15 Aug 2025, VivoSim Labs (VIVS) is trading at a price of 1.80, with a previous close of 1.80. The stock has fluctuated within a day range of 1.80 to 1.86, while its 52-week range spans from 1.41 to 21.96.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.